VIVEK RAMASWAMY (born August 9, 1985) is an American entrepreneur in the biotechnology sector. He is the founder and CEO of the pharmaceutical company Roivant Sciences.

As of April 2017, he is worth an estimated $600 million.[1]


Early life and education

He is the eldest son in his family. His father worked at General Electric and his mother, Geetha Ramaswamy, is a geriatric psychiatrist.[2]

Ramaswamy graduated from St. Xavier High School in Cincinnati in 2003.[3] He graduated _summa cum laude_ from Harvard College with an A.B. in biology. He then received a J.D. from Yale Law School, where his studies were supported by The Paul & Daisy Soros Fellowships for New Americans. [4]


Career

Ramaswamy was an investor in the biotechnology sector. In 2007, he co-founded and served as President of Campus Venture Network, a technology company that was acquired in 2009 by the Ewing Marion Kauffman Foundation. Ramaswamy worked at QVT Financial from 2007 to 2014, where he was a partner and co-managed the firm’s biotech portfolio.[5]

Ramaswamy is the founder and CEO of the pharmaceutical company Roivant Sciences. He is also the founder of Axovant Sciences, a clinical-stage pharmaceutical company focusing on treatments for dementia. The initial public offering for Axovant in 2015 raised $360 million, making it the largest biotech IPO in U.S. history.

Ramaswamy serves on the Board of Directors of Myovant Sciences, a subsidiary of Roivant Sciences focused on the treatment of women’s health diseases and other endocrine-related disorders. Myovant, formed in April 2016, raised $218 million in its initial public offering, the largest biotech IPO of 2016.[6]


References

Category:1985 births Category:Living people Category:Businesspeople from Cincinnati Category:Harvard University alumni Category:Yale Law School alumni Category:American company founders Category:Chief executives in the pharmaceutical industry Category:St. Xavier High School (Cincinnati) alumni

[1]

[2]

[3]

[4]

[5]

[6]